WALTHAM, Mass., Jan 04, 2011 (BUSINESS WIRE) --
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the JPMorgan 29th Annual Healthcare Conference on Monday, January 10, 2011, at 8:00 a.m. PT (11:00 a.m. ET) from the Westin St. Francis Hotel in San Francisco. The presentation may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL(R) for alcohol and opioid dependence and manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.
SOURCE: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 781-609-6823
Corporate Communications